Skip to main content

Table 1 Clinical and pathological characteristics of patients with DLBCL in our study

From: An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy

CharacteristicTraining datasetValidating dataset
(GSE31312)(GSE10846)
Sample size449342
Age, years mean (SD)61.81 (14.75)61.24 (15.48)
Gender
 Female189144
 Male260182
 Unknown016
Stage
 112458
 296103
 310177
 4128104
 Unknown00
 ≥ 2 Extranodal sites10029
 ECOGa performance status > 18184
Microarray subtype
 GCB214147
 ABC193144
 Unclassified subtype4251
 Unknown00
Overall survival
 Time, years mean (SD)3.24 (2.14)2.80 (2.35)
 Death164148
  1. GCB germinal center B-cell-like subtype, ABC activated B-cell-like subtype, SD standard deviation
  2. aThe Eastern Cooperative Oncology Group (ECOG) performance score ranges from 0 to 3, with a higher score indicating greater impairment